https://mesowatch.org/news/2026/06/alintegimod-7hp349-mesothelioma-trial-nct06362369/ MesoWatch en 2026-06-07T00:00:00.000Z Oral Alintegimod (7HP349) Trial Adds Mesothelioma to Its Cohorts clinical-trial, immunotherapy, alintegimod, 7hp349, nct06362369, research https://mesowatch.org/images/cards/alintegimod-7hp349-mesothelioma-trial-nct06362369-2026.jpg https://mesowatch.org/news/2026/06/italian-mesothelioma-immune-profiling-study-nct06581549/ MesoWatch en 2026-06-07T00:00:00.000Z Italian Imaging-Meso Study Maps the Mesothelioma Immune Map clinical trial, nct06581549, biomarkers, gene expression profiling, immune microenvironment, peritoneal mesothelioma, research https://mesowatch.org/images/cards/italian-mesothelioma-immune-profiling-study-nct06581549-2026.jpg https://mesowatch.org/news/2026/06/mdna11-il2-superkine-mesothelioma-trial-nct05086692/ MesoWatch en 2026-06-07T00:00:00.000Z MDNA11 IL-2 Superkine Trial Includes Pleural Mesothelioma clinical-trial, mdna11, il-2-superkine, immunotherapy, pembrolizumab, mesothelioma, treatment https://mesowatch.org/images/cards/mdna11-il2-superkine-mesothelioma-trial-nct05086692-2026.jpg https://mesowatch.org/news/2026/06/rina-s-mesothelioma-trial-nct05579366/ MesoWatch en 2026-06-07T00:00:00.000Z Rina-S Trial Adds Mesothelioma to Its Tumor Cohorts clinical-trial, antibody-drug-conjugate, rina-s, rinatabart-sesutecan, nct05579366, research https://mesowatch.org/images/cards/rina-s-mesothelioma-trial-nct05579366-2026.jpg https://mesowatch.org/news/2026/06/tng462-mesothelioma-trial-nct05732831/ MesoWatch en 2026-06-07T00:00:00.000Z TNG462 Trial: PRMT5 Inhibitor for MTAP-Deleted Mesothelioma clinical-trial, targeted-therapy, tng462, prmt5, mtap, nct05732831, research https://mesowatch.org/images/cards/tng462-mesothelioma-trial-nct05732831-2026.jpg https://mesowatch.org/news/2026/06/vet3-tgi-atezolizumab-stealth-001-trial-nct06444815/ MesoWatch en 2026-06-07T00:00:00.000Z STEALTH-001 Trial Tests VET3-TGI Oncolytic Virus in Solid Tumors clinical-trial, immunotherapy, oncolytic-virus, atezolizumab, nct06444815, research https://mesowatch.org/images/cards/vet3-tgi-atezolizumab-stealth-001-trial-nct06444815-2026.jpg https://mesowatch.org/news/2026/06/vt3989-tead-inhibitor-mesothelioma-trial-nct04665206/ MesoWatch en 2026-06-07T00:00:00.000Z VT3989 TEAD Inhibitor Trial Opens to Mesothelioma Patients clinical-trial, vt3989, tead-inhibitor, mesothelioma, treatment, research, nct04665206 https://mesowatch.org/images/cards/vt3989-tead-inhibitor-mesothelioma-trial-nct04665206-2026.jpg